944. Deputy Barry Ward asked the Minister for Children, Disability and Equality if she recognises the role of the proposed AgoraEU programme in supporting democracy, equality, civil society organisations and fundamental rights initiatives across the European Union, including support for organisations working with marginalised communities such as LGBTQ+ people; and if she will make a statement on the matter. [38479/26…
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
1,267 questions match, newest first.
945. Deputy Barry Heneghan asked the Minister for Health if she is aware of concerns regarding the sale of products commonly referred to as "CALI pens", marketed as CBD vapes, including reports that some may contain synthetic cannabinoids; the legal status of such products under current drugs legislation; the enforcement powers available to An Garda Síochána in relation to their sale, particularly to minors; and if s…
946. Deputy Máire Devine asked the Minister for Health whether she, or appropriate senior management staff from her Department, will meet with a person regarding issues experienced using the redress medical card programme (details supplied).; and if she will make a statement on the matter. [37617/26]
947. Deputy Ken O'Flynn asked the Minister for Health whether any service-specific clinical governance framework exists in areas where the HSE has confirmed that no structured national data collection system is currently in place; and if she will provide copies of any such framework. [36532/26]
948. Deputy Ken O'Flynn asked the Minister for Health whether any formal risk assessment has been undertaken regarding the absence of national audit and monitoring systems in certain healthcare pathways; and if so, to provide the date and findings of such assessments. [36533/26]
949. Deputy Ken O'Flynn asked the Minister for Health whether the Department has received legal advice regarding the State's safeguarding and patient-safety obligations in circumstances where national audit mechanisms are absent. [36534/26]
950. Deputy Ken O'Flynn asked the Minister for Health how the HSE measures compliance with clinical governance standards in service areas where no national outcome dataset or audit infrastructure currently exists. [36535/26]
951. Deputy Ken O'Flynn asked the Minister for Health whether any external or independent review has been commissioned into the adequacy of governance and safeguarding arrangements in healthcare pathways where national data systems remain under development. [36536/26]
952. Deputy Ken O'Flynn asked the Minister for Health whether the Department considers reliance on general HSE governance structures, without dedicated national audit systems, sufficient to satisfy the State's obligations under patient-safety and safeguarding frameworks. [36537/26]
953. Deputy Ken O'Flynn asked the Minister for Health whether her Department considers it acceptable that it does not receive national waiting-list data for PrEP services; whether this limits ministerial oversight of access to HIV prevention; and if she will make a statement on the matter. [36538/26]
954. Deputy Ken O'Flynn asked the Minister for Health whether she will require the HSE to provide quarterly national reporting on PrEP waiting times, demand, capacity and unmet clinical need. [36539/26]
955. Deputy Ken O'Flynn asked the Minister for Health whether the estimated excess demand of approximately 30% for PrEP services has now been eliminated following additional capacity introduced in Q3 and Q4 2025; and if not, the current estimated level of excess demand. [36540/26]
956. Deputy Ken O'Flynn asked the Minister for Health whether a national maximum waiting-time standard for access to PrEP services will be introduced under the forthcoming sexual health Model of Care. [36541/26]
957. Deputy Ken O'Flynn asked the Minister for Health whether her Department has set any national target for the number of public and private PrEP providers required to meet demand in each region. [36542/26]
958. Deputy Ken O'Flynn asked the Minister for Health whether she has received any assessment from the HSE on geographic disparities in access to PrEP services, including rural and regional access gaps. [36543/26]
959. Deputy Ken O'Flynn asked the Minister for Health whether a centralised national PrEP access register or demand-tracking system will be established. [36544/26]
960. Deputy Ken O'Flynn asked the Minister for Health whether her Department has assessed the public-health risk arising where clinically eligible individuals cannot access PrEP within a clinically appropriate timeframe. [36545/26]
961. Deputy Ken O'Flynn asked the Minister for Health the date by which the sexual health Model of Care will be completed; and whether it will include specific capacity targets, access standards, and reporting obligations for PrEP services. [36546/26]
962. Deputy Ken O'Flynn asked the Minister for Health whether her Department will publish annual national data on PrEP access, including provider numbers, waiting times, regional capacity, expenditure and unmet demand. [36547/26]
963. Deputy Shane Moynihan asked the Minister for Health the current availability of child psychology, occupational therapy and physiotherapy services in Cherry Orchard Primary Care Centre; the number of children awaiting each service; the average waiting times for assessment in each discipline in tabular form; and if she will make a statement on the matter. [36559/26]
964. Deputy Ken O'Flynn asked the Minister for Health whether any internal HSE operational manual, assessment framework, decision-support document, checklist, or staff guidance exists for officials administering the Treatment Abroad Scheme beyond the EU Regulations themselves; and if so, if copies will be provided. [36560/26]
965. Deputy Ken O'Flynn asked the Minister for Health whether officials administering the treatment abroad scheme are required to follow any standardised evidential criteria when assessing whether treatment is unavailable within the State or unavailable within a clinically appropriate timeframe. [36561/26]
966. Deputy Ken O'Flynn asked the Minister for Health whether any audit, quality assurance, peer review, or consistency-review mechanism exists for treatment abroad scheme eligibility determinations; and if so, to provide details. [36562/26]
967. Deputy Ken O'Flynn asked the Minister for Health whether any appeals, reconsideration, or secondary review process exists for applicants refused approval under the treatment abroad scheme; and if so, to provide details of the process and annual refusal figures since 2020. [36563/26]
968. Deputy Ken O'Flynn asked the Minister for Health whether any category-specific governance arrangements apply to overseas referrals under the treatment abroad scheme involving gender-related healthcare interventions, including enhanced approval, audit, safeguarding, or specialist review requirements. [36564/26]